Yuya Oguro

650 citations

15 papers · 450 indexed · h-index 11

Molecular Biology
Organic Chemistry top 10%
Oncology
Pathology and Forensic Medicine
Computational Theory and Mathematics top 10%

Co-authors: Akira Hori Shinichi Imamura Hiroshi Miki Naoki Miyamoto Hidehisa Iwata Terufumi Takagi Kengo Okada Keiji Kamiyama
Topics: Cancer therapeutics and mechanisms (4 papers)HER2/EGFR in Cancer Research (4 papers)Angiogenesis and VEGF in Cancer (4 papers)
Cited by: Toxicology Organic Chemistry Molecular Biology
Journals: Cancer Research Journal of Medicinal Chemistry Chemical Science
Partner nations: Japan United States

In The Last Decade

Yuya Oguro

14 papers receiving 436 citations

Peers

Countries citing papers authored by Yuya Oguro

Since Specialization

Citations

This map shows the geographic impact of Yuya Oguro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuya Oguro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuya Oguro more than expected).

Fields of papers citing papers by Yuya Oguro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuya Oguro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuya Oguro. The network helps show where Yuya Oguro may publish in the future.

Co-authorship network of co-authors of Yuya Oguro

This figure shows the co-authorship network connecting the top 25 collaborators of Yuya Oguro. A scholar is included among the top collaborators of Yuya Oguro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuya Oguro. Yuya Oguro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	2 H -Thiazolo[4,5- d ][1,2,3]triazole: synthesis, functionalization, and application in scaffold-hopping 2024 ·Chemical Science ·(unknown),(unknown),(unknown),Yuya Oguro,(unknown),(unknown),Kenta Kato,Kei Muto,Junichiro Yamaguchi	0
2	Design and Synthesis of Novel Spiro Derivatives as Potent and Reversible Monoacylglycerol Lipase (MAGL) Inhibitors: Bioisosteric Transformation from 3-Oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl Moiety 2021 ·Journal of Medicinal Chemistry ·Shuhei Ikeda,Hideyuki Sugiyama,(unknown),Masataka Murakami,Minoru Nakamura,Yuya Oguro,Jumpei Aida,(unknown),Satoshi Sogabe,Douglas R. Dougan,Sean C. Gay,Ling Qin,Naoto Arimura,Yasuko Takahashi,Masako Sasaki,Yusuke Kamada,Kazunobu Aoyama,(unknown),(unknown)	26
3	Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 Inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Antitumor Agent 2020 ·Journal of Medicinal Chemistry ·Osamu Kurasawa,T. Miyazaki,Misaki Homma,Yuya Oguro,Takashi Imada,Noriko Uchiyama,Kenichi Iwai,Yukiko Yamamoto,Momoko Ohori,(unknown),Hiroshi Sugimoto,Kentaro Iwata,R.J. Skene,Isaac Hoffman,Akihiro Ohashi,Toshiyuki Nomura,Nobuo Cho	16
4	Identification of a new class of potent Cdc7 inhibitors designed by putative pharmacophore model: Synthesis and biological evaluation of 2,3-dihydrothieno[3,2-d]pyrimidin-4(1H)-ones 2017 ·Bioorganic & Medicinal Chemistry ·Osamu Kurasawa,Yuya Oguro,T. Miyazaki,Misaki Homma,Kouji Mori,Kenichi Iwai,(unknown),R.J. Skene,Isaac Hoffman,Akihiro Ohashi,Sei Yoshida,Tomoyasu Ishikawa,Nobuo Cho	14
5	2-Aminomethylthieno[3,2-d]pyrimidin-4(3H)-ones bearing 3-methylpyrazole hinge binding moiety: Highly potent, selective, and time-dependent inhibitors of Cdc7 kinase 2017 ·Bioorganic & Medicinal Chemistry ·Osamu Kurasawa,Misaki Homma,Yuya Oguro,T. Miyazaki,Kouji Mori,Noriko Uchiyama,Kenichi Iwai,Akihiro Ohashi,(unknown),Sei Yoshida,Nobuo Cho	10
6	Design, synthesis, and evaluation of novel VEGFR2 kinase inhibitors: Discovery of [1,2,4]triazolo[1,5-a]pyridine derivatives with slow dissociation kinetics 2013 ·Bioorganic & Medicinal Chemistry ·Yuya Oguro,Douglas R. Cary,Naoki Miyamoto,Michiko Tawada,Hidehisa Iwata,Hiroshi Miki,Akira Hori,Shinichi Imamura	38
7	Discovery of N-[5-({2-[(cyclopropylcarbonyl)amino]imidazo[1,2-b]pyridazin-6-yl}oxy)-2-methylphenyl]-1,3-dimethyl-1H-pyrazole-5-carboxamide (TAK-593), a highly potent VEGFR2 kinase inhibitor 2013 ·Bioorganic & Medicinal Chemistry ·Naoki Miyamoto,Nozomu Sakai,Takaharu Hirayama,Kazuhiro Miwa,Yuya Oguro,Hideyuki Oki,Kengo Okada,Terufumi Takagi,Hidehisa Iwata,(unknown),Seiji Yamasaki,Toshiyuki Takeuchi,Hiroshi Miki,Akira Hori,Shinichi Imamura	64
8	Design, synthesis, and biological activities of novel hexahydropyrazino[1,2-a]indole derivatives as potent inhibitors of apoptosis (IAP) proteins antagonists with improved membrane permeability across MDR1 expressing cells 2013 ·Bioorganic & Medicinal Chemistry ·Zenyu Shiokawa,Kentaro Hashimoto,Bunnai Saito,Yuya Oguro,Hiroyuki Sumi,Masato Yabuki,(unknown),Yohei Kosugi,(unknown),(unknown),Douglas R. Dougan,G. Snell,Sei Yoshida,Tomoyasu Ishikawa	16
9	A novel pyrrolo[3, 2‐d]pyrimidine derivative, as a vascular endothelial growth factor receptor and platelet‐derived growth factor receptor tyrosine kinase inhibitor, shows potent antitumor activity by suppression of tumor angiogenesis 2012 ·Cancer Science ·(unknown),Akio Mizutani,(unknown),Hidehisa Iwata,Yuya Oguro,Hiroshi Miki,Shinichi Imamura,Akira Hori	9
10	Discovery of pyrrolo[3,2-c]quinoline-4-one derivatives as novel hedgehog signaling inhibitors 2012 ·Bioorganic & Medicinal Chemistry ·Tomohiro Ohashi,Yuya Oguro,Toshio Tanaka,Zenyu Shiokawa,Sachio Shibata,Yoshihiko Sato,(unknown),(unknown),Yukiko Yamamoto,Shigeru Kondo,Maki Miyamoto,Hideaki Tojo,Atsuo Baba,Satoshi Sasaki	55
11	Design, synthesis, and evaluation of imidazo[1,2-b]pyridazine derivatives having a benzamide unit as novel VEGFR2 kinase inhibitors 2012 ·Bioorganic & Medicinal Chemistry ·Naoki Miyamoto,Yuya Oguro,Terufumi Takagi,Hidehisa Iwata,Hiroshi Miki,Akira Hori,Shinichi Imamura	19
12	Discovery of the investigational drug TAK-441, a pyrrolo[3,2-c]pyridine derivative, as a highly potent and orally active hedgehog signaling inhibitor: Modification of the core skeleton for improved solubility 2012 ·Bioorganic & Medicinal Chemistry ·Tomohiro Ohashi,Yuya Oguro,Toshio Tanaka,Zenyu Shiokawa,Yuta Tanaka,Sachio Shibata,Yoshihiko Sato,(unknown),(unknown),Yukiko Yamamoto,Shigeru Kondo,Maki Miyamoto,Mitsuhiro Nishihara,(unknown),Hideaki Tojo,Atsuo Baba,Satoshi Sasaki	60
13	Abstract 2823: TAK-441, a novel investigational small molecule hedgehog pathway inhibitor for use in cancer therapy 2011 ·Cancer Research ·Hideaki Tojo,Sachio Shibata,Yoshihiko Satoh,Mihoko Kawamura,Masakazu Inazuka,(unknown),Masahide Kashiwagi,Maki Miyamoto,Shigeru Kondo,(unknown),Yuya Oguro,Satoshi Sasaki	2
14	N-Phenyl-N′-[4-(5H-pyrrolo[3,2-d]pyrimidin-4-yloxy)phenyl]ureas as novel inhibitors of VEGFR and FGFR kinases 2010 ·Bioorganic & Medicinal Chemistry ·Yuya Oguro,Naoki Miyamoto,Terufumi Takagi,Kengo Okada,(unknown),Hiroshi Miki,Akira Hori,Keiji Kamiyama,Shinichi Imamura	26
15	Design, synthesis, and evaluation of 5-methyl-4-phenoxy-5H-pyrrolo[3,2-d]pyrimidine derivatives: Novel VEGFR2 kinase inhibitors binding to inactive kinase conformation 2010 ·Bioorganic & Medicinal Chemistry ·Yuya Oguro,Naoki Miyamoto,Kengo Okada,Terufumi Takagi,Hidehisa Iwata,(unknown),Hiroshi Miki,Akira Hori,Keiji Kamiyama,Shinichi Imamura	95

About Yuya Oguro

Yuya Oguro is a scholar working on Toxicology, Oncology and Molecular Biology, having authored 15 papers that have together received 450 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (4 papers), HER2/EGFR in Cancer Research (4 papers) and Angiogenesis and VEGF in Cancer (4 papers). The work is most often cited by research in Toxicology (39 citations), Organic Chemistry (205 citations) and Molecular Biology (263 citations). Yuya Oguro has collaborated with scholars based in Japan and United States. Frequent co-authors include Akira Hori, Shinichi Imamura, Hiroshi Miki, Naoki Miyamoto, Hidehisa Iwata, Terufumi Takagi, Kengo Okada, Keiji Kamiyama, Zenyu Shiokawa and Hideaki Tojo. Their work appears in journals such as Cancer Research, Journal of Medicinal Chemistry and Chemical Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact